Upcoming "MSU Lecture" with Prof. Anton Wellstein from the Lombardi Comprehensive Cancer C
On Tuesday, 8th of May 2018, Prof. Dr. Anton Wellstein, Associate Director for Basic and Translational Science of the Lombardi...
Deutsche Krebshilfe funds innovative research project on papillary thyroid c
The Deutsche Krebshilfe funds MSU with a grant to study papillary thyroid carcinoma (PTC) - one of the most common types of thyroid...
Upcoming "New Horizons in Oncology Lecture" with Prof. Johanna Ivaska from Turku, Finland
Next Tuesday, 7th of November, Prof. Johanna Ivaska, upcoming leader in the field of molecular cancer research, from Center of...
Ubiquitin dependent regulation of Cdc42!
Cdc42 is one of the well studied Rho GTPases primarily known for the regulation of filopodia in cells. While most of the studies were...
Joint FTN/MSU Seminar feat. Dr. Jay Gopalakrishnan
Tomorrow, Tuesday, 13th of June, we have the honor to host one of the upcoming leaders in the field of Neurobiology. Dr. Jay...
Novel Avenue to target KRAS-mediated lung Cancers
According to the WHO, lung cancer is a major cause of cancer related deaths and KRAS is the most frequently mutated oncogene (nearly 17%...
Official opening of the Paul Klein Center for Immune Intervention
Today, MSU´s future "new homestead", the Paul Klein Center for Immune Intervention was officially opened. In a well-organized event...
API 5 is an endogenous Inhibitor of Caspase-2!
Caspases are key enzymes responsible for mediating apoptosis and initiator caspases are activated by dimerization. Work from MSU Mainz...
MSU Mainz part of award-winning UBAUT program!
Cited from UBAUT homepage (www.ubaut.de): "Let's talk about UBAUT is one of the winning concepts of the 2016 Idea’s Competition for...
Next Event in "New Horizons in Oncology" Lecture Series on March, 14th 2017!
In our Flagship Lecture Series "New Horizons in Oncology" we are happy to welcome our next speaker: On Tuesday, March, 14th, Dr. Anna...
